A statement of changes in beneficial ownership was filed on November 3, 2026, disclosing that Dr. Ethan Shen resigned as a director and Chief Technology Officer of SL Science Holding Ltd (NASDAQ:SLBT), effective November 1, 2026.

Key Highlights

  • Resignation date: Dr. Ethan Shen's departure as a director and Chief Technology Officer of SL Science Holding Ltd became effective November 1, 2026.
  • Reporting person: Ethan Shen PhD, whose address on the filing is listed as 11th Floor, No. 479 Chongyang Road, Nangang District, Taipei, Taiwan 115010.
  • Section 16 status: According to the filing, Dr. Shen is "no longer subject to Section 16 reporting" following his resignation.
  • No securities transactions reported: Tables I and II in the filing contain no reported acquisitions, disposals, or derivative security transactions.
  • Filing type: The box indicating the reporting person is "no longer subject to Section 16" obligations is checked on the filing.

Dr. Shen's Departure from SL Science Holding and Its Filing Context

According to the filing, Dr. Ethan Shen served as both a member of the board of directors and as Chief Technology Officer of SL Science Holding Ltd, which trades on NASDAQ under the symbol SLBT. His dual role placed him among the company's senior leadership responsible for technology strategy. The filing identifies his prior relationship to the issuer as "Former Director and CTO," reflecting that both positions ended simultaneously on November 1, 2026.

The filing was submitted on November 3, 2026, and was signed by Dr. Shen. It was filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, which requires officers, directors, and large shareholders of public companies to disclose changes in their beneficial ownership. The filing's remarks section states verbatim: "Effective November 1, 2026, Dr. Ethan Shen resigned as a director of the board and Chief Technology Officer of SL Science Holding Limited, and therefore is no longer subject to Section 16 reporting." No transaction data appears in either the non-derivative or derivative securities tables, as there were no acquisitions or disposals to report in connection with this filing.

SL Science Holding Ltd is listed on NASDAQ. The filing does not describe the company's business operations, financial results, or any transition plans related to the CTO position. No shares were reported as beneficially owned following the filing, and no price or share count figures appear in the transaction tables.

What Was Disclosed

The filing disclosed that Dr. Ethan Shen resigned from his roles as director and Chief Technology Officer of SL Science Holding Ltd on November 1, 2026, terminating his Section 16 reporting obligations. No securities transactions were reported in connection with the departure.